Global longitudinal strain as a predictor of outcomes in chronic Chagas´ cardiomyopathy

Minna Moreira Dias Romano1, Henrique Turin Moreira1, Fawaz Alenezi2

  • 1Cardiology Center of the Medical School of Ribeirao Preto, University of São Paulo (USP), São Paulo, Brazil.

PubMed

Insights

Global longitudinal strain (GLS) predicts cardiovascular events in Chronic Chagas cardiomyopathy (CCC). This finding offers a new tool for risk stratification in Chagas disease patients, independent of ejection fraction.

Area of Science:

  • Cardiology
  • Echocardiography
  • Medical Diagnostics

Background:

  • Chronic Chagas cardiomyopathy (CCC) significantly increases cardiovascular event risk.
  • Global longitudinal strain (GLS) shows prognostic value in various cardiomyopathies.
  • The predictive capability of GLS in CCC requires further investigation.

Purpose of the Study:

  • To evaluate the prognostic significance of GLS in patients with CCC.
  • To determine if GLS can predict adverse cardiovascular outcomes in CCC.
  • To assess the utility of GLS for risk stratification in Chagas disease.

Main Methods:

  • Retrospective echocardiography analysis with prospective follow-up.
  • GLS measured using vendor-independent software from LV apical peak longitudinal strain.
  • GLS categorized into tertiles for prognostic comparison.

Main Results:

  • GLS was assessed in 77 CCC patients (mean age 56 ± 15 years).
  • After 35 ± 19 months, 33 patients experienced composite adverse outcomes.
  • Higher GLS values (≥ -13.8%) were significantly associated with worse prognosis (log rank p=0.001).
  • Multivariate analysis confirmed GLS as an independent predictor of outcomes (HR 1.20, p=0.008), adjusted for age, gender, and LVEF.

Conclusions:

  • Left ventricle GLS independently predicts cardiovascular outcomes in CCC patients.
  • GLS serves as a valuable tool for risk stratification in Chagas disease, irrespective of LVEF.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
56
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
58